2nd Swiss Industrial Chemistry Symposium, SICS 2018
| Start Date | 19.10.2018 - 08:30 |
| Event End | 19.10.2018 - 19:00 |
| Location | Universität Basel, Organische Chemie |
The symposium offers a unique platform for industrial scientists, working in research and process research, to present their latest results, to interact with each other and to network with professors, PhD students and other scientific staff of Swiss universities. An extended poster session with presentations from industry (20%) and academy (80%) will stimulate the interaction.
Flyer Swiss Industrial Chemistry Symposium 2018 (SICS'18)
Confirmed Speakers:
- Dr. Silvio Roggo, Senior Investigator, Natural Products Chemistry, Novartis AG, «Reengineering and Repurposing of Cyclosporins»
- Dr. Marc Thommen, Head CMC, Polyphor Ltd, Allschwil, and Dr. Stefan Eissler, Bachem AG, Bubendorf, «Murepavadin - A novel antibiotic overcoming bacterial resistance and its challenging manufacture on large scale»
- Dr. Michael Levis, Siegfried AG, «From Lab to Plant – achieving better process performance on scale using new lab technologies and data management tools»
- Dr. Christian Chapuis, Firmenich SA, «Synthesis of Methyl Jasmonate and Analogues»
- Dr. Andreas Hafner, BASF Schweiz AG, Basel, «Vision “24h daylight illumination in buildings"»
- Dr. Andreas Gloger, Philochem AG, «DNA-encoded chemical libraries»
- Dr. Christof Aellig, LONZA, Visp, «Lonza's advances in flow chemistry»
- Dr. Paul Hebeisen, PIQUR Therapeutics AG, Basel, «What a Difference a Dalton Makes. From the University Lab to PIQUR»
- Dr. Craig Harris, Head of Research Synthesis, Nestlé Skin Health/ Galderma S.A., Lausanne, «Design and Synthesis of Novel Peptidomimetic Caspase I Inhibitors as a Novel Topical Treatment for Acne»
- Dr. Werner Bonrath, DSM Nutritional Products, «Future of Catalysis in Fine Chemical Industry»
- Dr. Thomas Fessard, Spirochem AG, «New trends and tactics in bioisosteric switch strategies»
- Dr. Vit Lellek, Cilag/ Johnson & Johnson, «From Process Development of a potent Cathepsin S-Inhibitor to efficient Syntheses of Pyrazoles»
- Dr. Thomas Woltering and Dr. Jean-Michel Adam, F. Hoffmann-La Roche AG, Basel, «BACE1 Inhibitor - from 12mg to 7kg: A Great Mix of Challenges, "Surprises" & Achievements»
- Dr. Christoph Boss, Idorsia Pharmaceuticals Ltd., Allschwil, «Discovery and Characterization of ACT-541468, an Orally Available, Brain Penetrant Dual Orexin Receptor Antagonist with Potent Sleep Promoting Properties»
- Dr. Clemens Lamberth, Syngenta Crop Protection AG, Stein (AG), «How Rarely Used Reactions enabled the Synthesis of Highly Active Fungicides»
- Dr. Ralf Dümpelmann, BaselArea.Swiss: promoting and enabling innovation
Contact:
Co-Chairman and Program Coordinator
Dr. Remo Gamboni
F. Hoffmann-La Roche AG
4070 Basel
+41 61 688 24 58